Narciso, Rishar Maze .
HRN: 24-11-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2025
CEFTRIAXONE 1G (VIAL)
11/06/2025
11/13/2025
IV DRIP
1g
Q12
PCAP C; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes